Related Experiment Video
Updated: Mar 8, 2026

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence
Published on: January 7, 2019
DUSP1 inhibits cell proliferation, metastasis and invasion and angiogenesis in gallbladder cancer
Jiliang Shen1, Senjun Zhou1, Liang Shi1
1Department of General Surgery, Sir Run-Run Shaw Hospital, Zhejiang University, Hangzhou 310016, China.
Abstract:
DUSP1/MKP1 is a dual-specific phosphatase that regulates MAPK activity and is known to play a key role in tumor biology. Its function in gallbladder cancer (GBC) remains largely unknown, however. By exploring its activities in two GBC cell lines (SGC996 and GBC-SD), DUSP1 was found to inhibit GBC cell proliferation, migration and invasion. Moreover, DUSP1 inhibited GBC growth and metastasis in nude mice subcutaneously xenografted with SGC996 cells. The tumor suppression appeared to be mediated via the DUSP1-pERK/MAPK-MMP2 signal pathway. Angiogenesis was associated with the tumor metastasis in the mouse model and was impaired by DUSP1, which suppressed VEGF expression. These results suggest that DUSP1 suppresses GBC growth and metastasis by targeting the DUSP1-pERK-MMP2/VEGF axis. Identification of the DUSP1-pERK-MMP2/VEGF signals may provide new biomarkers and/or therapeutic targets to better suppress GBC metastasis in the future.
Insights
Dual-specific phosphatase DUSP1 inhibits gallbladder cancer (GBC) growth and metastasis. Targeting the DUSP1-pERK-MMP2/VEGF pathway may offer new therapeutic strategies for GBC.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Dual-specificity phosphatase 1 (DUSP1/MKP1) regulates mitogen-activated protein kinase (MAPK) signaling.
- DUSP1 plays a role in various cancers, but its function in gallbladder cancer (GBC) is largely uncharacterized.
Purpose of the Study:
- To investigate the role and mechanism of DUSP1 in gallbladder cancer (GBC) progression.
- To explore DUSP1 as a potential therapeutic target for GBC.
Main Methods:
- In vitro studies using GBC cell lines (SGC996 and GBC-SD) to assess proliferation, migration, and invasion.
- In vivo studies using a mouse xenograft model with SGC996 cells to evaluate tumor growth and metastasis.
- Analysis of signaling pathways including DUSP1-pERK/MAPK-MMP2 and VEGF expression.
Main Results:
- DUSP1 significantly inhibited GBC cell proliferation, migration, and invasion in vitro.
- DUSP1 suppressed GBC tumor growth and metastasis in vivo.
- Tumor suppression by DUSP1 was mediated through the DUSP1-pERK/MAPK-MMP2 signaling pathway.
- DUSP1 impaired angiogenesis by suppressing VEGF expression, thereby reducing tumor metastasis.
Conclusions:
- DUSP1 acts as a tumor suppressor in gallbladder cancer.
- DUSP1 inhibits GBC growth and metastasis by regulating the DUSP1-pERK-MMP2/VEGF axis.
- The DUSP1-pERK-MMP2/VEGF signaling pathway represents a potential target for novel GBC therapies and biomarkers.
Related Concept Videos
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Abnormal Proliferation
Cancer Cell Migration through Invadopodia

